Whilst SLC1A5 (also known as Alanine Serine Cysteine Transporter 2, ASCT2) is a neutral amino acid transporter with ubiquitous expression, overexpression of this gene has been discovered in various cancers22, 23, and it is currently being explored as a possible drug target for cancer treatment24. The gene discussed is SLC1A5; the disease is cancer.